GlaxoSmithKline PLC (GSK.L) News Headlines

▮ More

Date

Headline

7/15/2019 2:13:45 AM GSK: Phase 3 PRIMA Study Of ZEJULA To Treat Ovarian Cancer Meets Primary Goal

7/15/2019 2:02:30 AM GSK Announces Positive Headline Results In Phase 3 PRIMA Study Of ZEJULA

7/10/2019 2:50:33 AM ViiV : 2-drug Regimen Of Dolutegravir Plus Lamivudine Effective To Control HIV-1

7/10/2019 2:11:00 AM GSK: ViiV Healthcare Announces Phase III TANGO Study Meets Primary Endpoint

7/3/2019 4:33:40 AM ViiV Healthcare Reports Marketing Authorisation Of Dovato In Europe

7/3/2019 4:14:29 AM GSK: ViiV Healthcare Receives EU Marketing Authorisation For Dovato

6/24/2019 8:05:24 AM SpeeDx Announce Collaborative Agreement With GSK To Supply Tests And Technology

6/7/2019 7:14:03 AM STADA Buys Six Of GSK's Consumer Brand

6/7/2019 6:10:29 AM STADA To Buy Five Skin Care Brands And A Pediatric Cough Remedy From GSK

6/7/2019 2:21:05 AM GSK: Nucala Gets FDA Approval For Two New Self-administration Options

6/7/2019 2:02:20 AM GSK: FDA Approves Two New Methods For Administering Nucala

5/16/2019 5:28:23 AM Thermo Fisher To Buy GSK's API Manufacturing Site In Cork, Ireland For €90 Mln

5/16/2019 5:10:01 AM Thermo Fisher Scientific To Acquire A Drug Substance Manufacturing Site In Ireland, From GSK For EUR 90 Mln Cash

5/4/2019 12:20:13 PM Vectura Wins US GSK Patent Litigation;awarded $89.7Mln In Damages By Trial Jury

5/1/2019 8:42:01 AM GSK Q1 Profit Rises

5/1/2019 8:03:24 AM GlaxoSmithKline Q1 Total EPS 16.8p, Up 50% AER, Up 42% CER

4/29/2019 9:16:37 AM ViiV Healthcare Seeks FDA Approval For Two-drug To Treat HIV-1 Infection

4/29/2019 8:35:57 AM GlaxoSmithKline: ViiV Submits NDA For HIV Monthly 2 Drug Injectable

4/24/2019 2:22:47 AM World's First Malaria Vaccine Launched

4/18/2019 3:29:10 AM Mustang Bio Gallops On Gene Therapy Trial Results For Bubble Boy Disease

Glaxosmithkline Plc (GSK.L)